Related Experiment Video
Updated: Mar 24, 2026
07:13
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
5.4K
Calcineurin Inhibitor Minimization, Conversion, Withdrawal, and Avoidance Strategies in Renal Transplantation: A
D Sawinski1, J Trofe-Clark1,2, B Leas3
1Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
Summary
Reducing calcineurin inhibitor (CNI) exposure in kidney transplant patients via minimization or withdrawal may improve outcomes, but carries increased rejection risks. Further research is needed for optimal immunosuppression strategies.
Area of Science:
- Nephrology
- Immunosuppression
- Transplantation
Background:
- Calcineurin inhibitors (CNIs) are effective but toxic for renal transplant recipients.
- Reducing CNI exposure is a key goal for improving long-term outcomes.
Purpose of the Study:
- To systematically review and meta-analyze CNI minimization, conversion, withdrawal, and avoidance strategies.
- To assess the impact of these strategies on patient/allograft survival, rejection, and renal function.
Main Methods:
- Systematic review and meta-analysis of 88 randomized controlled trials (92 comparisons).
- Evaluation of four CNI reduction strategies: minimization, conversion, withdrawal, and avoidance.
Main Results:
- CNI minimization showed improved clinical outcomes versus standard doses.
- Conversion to mTOR inhibitors or belatacept improved renal function but increased rejection.
- Planned CNI withdrawal improved renal function but was associated with higher rejection rates.
- Evidence for CNI avoidance was insufficient.
Conclusions:
- CNI minimization and withdrawal strategies offer potential benefits but require careful risk-benefit assessment.
- Further research is needed for tacrolimus-based regimens, higher-risk populations, and patient-centered outcomes.
Related Concept Videos
01:26Kidney Transplant II: Surgical Procedure
742
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
742
01:16Kidney Transplant III: Nursing Management
547
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
547
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
459
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
459
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
301
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
301
01:22Drug Elimination by Renal Route: Tubular Reabsorption
5.5K
During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
5.5K
01:11Renal Failure: Dose Adjustments
574
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
574